Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
23 Cards in this Set
- Front
- Back
Name 3 benign and 2 malignant tumours of the kidney along with cell of origin
|
Benign: adenoma (tubular epithelial cells), oncocytoma (intercalated cells of collecting duct), angiomyolipoma
Malignant: adenocarcinoma (renal tubular epithelium), urothelial carcinoma of the pelvis (urothelial cells) |
|
Papillary adenoma: cell origin and location, configuration, size
|
1. Cell origin and location: renal tubular epithelium in cortex
2. Configuration: papillary (most) 3. Size: <5cm |
|
Angiomyolipoma: composition, common association, clinical significance
|
1. Composition: blood vessels, smooth muscle, fat
2. Common association: tuberous sclerosis 3. Clinical significance: tendency to bleed |
|
Oncomyocytoma: Origin, etiology, gross appearance, size, microscopic appearance
|
1. Origin: intercalated cells of collecting ducts
2. Etiology: sporadic (most), familial 3. Gross appearance: tan mohogany brown, well-encapsulated 4. Size: up to 12cm 5. Microscopic appearance: large eosiniphillic cells |
|
Adenocarcinoma: Epidemiology, Risk Factors, Classification, Genetic Forms
|
1. Epidemiology: 85% of renal malignancies, 60-70's, males>females
2. Risk Factors: smoking, heavy metals, chronic renal failure, acquired cystic disease, obesity, HTN, unopposed estrogen therapy, asbestos, petroleum products, tuberous sclerosis 3. Types: clear cell (70-80%), papillary (10-15%), chromophobe (5%), collecting duct carcinoma (1%), translocation carcinoma (rare) 4. Genetic Forms: Von Hippel-Lindau syndrome, mutation in VHL gene with only kidneys affected, mutations of MET proto-onco genes (autosomal dominant, bilateral papillary RCC) |
|
Clear Cell Renal Cell Carcinoma: Etiology, Origin, Gross morphology, Microscopic morphology, Grading
|
1. Etiology: sporadic (95%) or familial (5%), solitary, unilateral, associated with VHL mutation
2. Origin: proximal renal tubule 3. Gross morphology: well-demarcated, golden yellow 4. Microscopic morphology: Clear cells surrounded by delicate vessels 5. Grading: Furhman nuclear grades 1-4 |
|
Papillary Renal Cell Carcinoma: Precursor, Etiology, Microscopic appearance
|
1. Precursor: papillary adenoma
2. Etiology: familial (trisomy 7 MET gene) and sporadic (trisomy 7,16,17, loss of Y) 3. Microscopic appearance: Papillary configuration, fibrovascular cores, foamy macrophages, psammoma bodies |
|
Chromophobe Renal Cell Carcinoma: Origin, Prognosis, Etiology, Gross morphology, Microscopic morphology
|
1. Origin: Intercalated cells of collecting duct
2. Prognosis: better than clear cell and papillary 3. Gross morphology: mahogany with central scar 4. Microscopic morphology: sheets of cells, eosinophilic, thic cell membrane, rasinoid nuclei with perinuclear halo |
|
Collecting Duct Carcinoma: Origin, Microscopic appearance, Prognosis
|
1. Origin: epithelium of collecting ducts in medulla of kidney
2. Microscopic appearance: malignant cells in densely fibrotic stroma 3. Prognosis: poor |
|
Urothelial Carcinoma of Renal Pelvis: Size, Association, Microscopic appearance
|
1. Size: small at presentation b/c cause hematuria
2. Association: bladder tumour 3. Microscopic appearance: identical to bladder tumour |
|
Name 5 types of urinary bladder tumours
|
1. Urothelial tumors: papillary, flat, invasive
2. Squamous neoplasms 3. Glandular neoplasms 4. Neuroendocrine tumours 5. Mesenchymal tumours |
|
Urothelial Lesions: Types + Grades + histology
|
1. Papillary: Hyperplasia; Neoplasms - Urothelial Papilloma (benign, fibrovascular cores covered with normal urothelium), papillary urothelial tumor of low malignant potential (thicker urothelium +/- mitoses), Low Grade Papillary Urothelial Carcinoma (thicker urothelium, enlarged nuclei, mitotic figures), High Grade Papillary Urothelial Carcinoma (thick urothelium, enlarged/crowded nuclei, nuclear atypia, mitoses)
2. Flat lesions: Normal, Hyperplasia, Flat Lesions with Atypia [reactive, dysplasia (low grade), carcinoma in situ (high grade)] 3. Invasive Urothelial Carcinoma: associated with high grade papillary urothelial carcinoma or flat CIS, degree of invasion into bladder impt for prognosis, variants (nested, micropapillary, lymphoepithelioma like) |
|
Testis Tumours Classification
|
1. Germ Cell tumours: Seminomatous (seminoma, spermatocytic seminoma)
Non-seminomatous (embryonal carcinoma, yolk sac tumor, teratoma, choriocarcinoma), Mixed 2. Sex Cord Stromal Tumours: Leydig Cell, Sertoli Cell |
|
Germ Cell Tumours: Epidemiology, Etiology, Types
|
1. Epidemiology: 95% of testicular tumours
2. Etiology: Genetic (associated with testicular dysgenesis syndrome), Environmental 3. Types: Seminoma, spermatocytic seminoma, embryonal carcinoma, yolk sac tumour, teratoma, choriocarcinoma, mixed |
|
Seminoma: Epidemiology, Prognosis, Morphology, Histology
|
1. Epidemiology: 50% of germ cell tumours, peak in 20's
2. Prognosis: aggressive but treatment cures 3. Morphology: uniform, gray/tan with necrosis or hemorrhage 4. Histology: Uniform sheets, lymphocytes, large central nucleus, syncytiotrophoblasts, granulomas |
|
Spermatocytic Seminoma: Epidemiology, Immunohistochemistry, Prognosis
|
1. Epidemiology: Less common than seminoma, over 65, slow growing
2. Immunohistochemistry: PLAP negative 3. Prognosis: excellent |
|
Embryonal Carcinoma: Epidemiology, Morphology, Histology
|
1. Epidemiology: 20-30s, aggressive
2. Morphology: necorsis and hemorrhage, extension through tunica albuginea into epididymis or spermatic cord 3. Histology: alveolar or tubular pattern |
|
Yolk Sac Tumour: Epidemiology, Prognosis, Morphology, Histology
|
1. Epidemiology: most common testicular tumour in children <3, rare in adults
2. Prognosis: good 3. Morphology: Non-encapsulated, white-yellow, mucinous 4. Histology: reticular network of flattened or cuboidal cells, Schiller-Duval bodies, hyaline bodies (positive for AFP and antitrypsin) |
|
Choriocarcinoma: Epidemiology, Morphology, Histology, Immunohistochemistry
|
1. Epidemiology: highly malignant, rare in pure form
2. Morphology: small palpable nodules, very hemorrhagic 3. Histology: mix of syncitio and cytotrophoblastic cells 4. Immunohistochemistry: Positive for HCG |
|
Teratoma: Epidemiology, Morphology, Histology
|
1. Epidiomology: Occur at any age but more common in infants, less common in pure form
2. Morphology: Heterogenous mix of different germ layer tissues 3. Histology: normal cells from various tissues, can become atypical |
|
Mixed Germ Cell Tumours: Epidemiology, Common Combinations
|
1. Epidemiology: 65-75% of germ line tumours
2. Combinations: Teratoma+embryonal carcinoma+yolk sac tumour, seminoma+embryonal carcinoma, embryonal carcinoma+teratoma |
|
Leydig Cell Tumours: Epidemiology, Secretions, Clinical Presentation, Morphology, Histology, Benign or Malignant
|
1. Epidemiology: any age
2. Secretions: androgens, estrogens, corticosteroids 3. Morphology: well circumscribed, <5cm, golden brown 4. Histology: Similar to normal cells but contain rod shaped Reinke crystals 5. Benign or Malignant: most benign |
|
Sertoli Cell Tumours: Benign or Malignant, Secretions, Morphology, Histology
|
1. Benign or Malignant: Most benign, 10% malignant
2. Secretions: hormonally silent 3. Morphology: small, firm nodules, homogenous ray-white-yellow 4. Histology: distinctive trabeculae that form cord-like structures and tubules |